CloudMD Software & Services, Inc.

Detailed Description

CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services. The company also retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies, as well as provides clinical services, such as medical reviews and compounding; and provides cloud-based electronic medical records (EMR) software, medical billing and practice management software, and various telemedicine platforms to medical professionals, as well as digital platforms to serve individuals for their eyecare and specialty drug needs. In addition, it offers JunoEMR, a cloud-based EMR solution; MyHealthAccess, an online patient portal for online appointment booking and telemedicine visits; Benchmark, a suite of cloud-based medical practice solutions; and ClinicAid, a medical billing software. Further, the company provides Livecare Connect, a telemedicine platform; IDYA4, a health data integration and security technology platform; VisionPros, an online eyecare platform that offers contact lenses and eyeglasses under the KIND brand; Rxi, a specialty drug wholesaler, pharmacy, and technology/patient support program administrator. Additionally, it provides enterprise health solutions, including mental health support; employee and student assistance programs; healthcare navigation and specialist; rehabilitation and assessments; education; and absence management. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Victoria, Canada.